As of October 2026, no payouts are final under the proposed $7.25 billion Roundup class settlement, and more than 60,000 active lawsuits remain. The proposal would resolve eligible current and future non-Hodgkin lymphoma claims, a cancer of the lymphatic system, linked to glyphosate-based Roundup exposure.
Bayer and attorneys for cancer patients announced the proposed deal on Feb. 17, 2026 to resolve claims that Bayer failed to warn Roundup could cause cancer, according to Associated Press via SRN News. The deal would pay up to $7.25 billion over 21 years as a nationwide class settlement, according to AgWeb reporting on Bayer's announcement.
Official resources:
- Read the official notice from Drugwatch — Use this primary source to verify the official announcement.
- Read the official notice from Srnnews — Use this primary source to verify the official announcement.
Table of Contents
- What are the proposed payout amounts?
- Has the court approved the settlement?
- Who falls under the proposed class?
- Does the Supreme Court ruling change individual cases?
- Frequently Asked Questions
What are the proposed payout amounts?
Under the 2026 proposal, standard awards for eligible non-Hodgkin lymphoma class members were described as $10,000 to $165,000. Quick-Pay awards were described as $6,000 to $14,500, plus added amounts for special situations. The ranges are not guarantees.
Final amounts depend on court approval, claim review, fund limits, and how many people qualify. Readers should compare their own diagnosis, exposure history, and claim category with an attorney. Those details matter more than averages because the class covers varied illness histories and timelines.
Has the court approved the settlement?
A Missouri judge granted preliminary approval on March 4, 2026. The final-approval hearing took place Sept. 14, 2026 before Judge Timothy Boyer in St. Louis City Circuit Court.
In September 2026, Bayer's Monsanto unit urged the judge to grant final approval, arguing no other path resolves the litigation, according to Missouri Lawyers Media. Objections focused on payout limits and attorney fees. No class payouts are final until the court grants final approval. Class members had to opt out by the 2026 deadline to preserve individual suits, and an August 2026 federal appeal over state-court jurisdiction was dismissed, according to Reuters.
Who falls under the proposed class?
The proposal covers eligible current and future non-Hodgkin lymphoma claims tied to Roundup exposure. As of October 2026, most active suits involve people alleging that diagnosis after glyphosate-based Roundup use, according to Drugwatch's October update.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
People who stayed in the class generally cannot pursue a separate lawsuit for the same covered claim. People who opted out by the deadline kept the right to pursue individual cases, but face litigation risks and delays.
- Confirm whether you filed a claim, registered, or opted out
- Gather product-use dates, purchase or work records, and medical records
- Ask a mass-tort attorney which claim track fits your diagnosis
- Watch the Missouri court's final-approval order before expecting payment
Does the Supreme Court ruling change individual cases?
On June 25, 2026, the U.S. Supreme Court ruled for Monsanto that federal law preempts state failure-to-warn labeling claims. The decision could affect thousands of suits, while negligence and product-defect claims survive, according to Consumer Notice's October update.
That split matters for strategy. A labeling claim may face dismissal, but a case built on defective design or negligent conduct can continue where the facts support it. Do not assume the ruling ends your claim or guarantees payment. Ask counsel how your petition is pleaded and whether amendment, opt-out status, or settlement participation is the stronger option.
Frequently Asked Questions
Will I be paid automatically if I used Roundup?
No. You must meet class rules, submit required proof, and wait for final court approval and claims review.
What if I missed the opt-out deadline?
You generally remain bound by the class outcome for covered claims. An attorney can explain narrow exceptions.
Are future NHL diagnoses covered?
The proposal includes eligible future claims, but coverage still turns on exposure, diagnosis, deadlines, and final approval.
You Might Also Like
- Depo Provera Lawsuit Settlement Update: What October 2026 Changed
- Spinal Cord Stimulator Lawsuit: October 2026 Eligibility Update
- VSL#3 Lawsuit Update: What the January 2027 Settlement Hearing Will Decide